| Bioactivity | β-Amino Acid Imagabalin Hydrochloride (PD-0332334) is a ligand for the α2δ subunit of the voltage-dependent calcium channel. |
| Target | Calcium channel |
| In Vivo | β-Amino Acid Imagabalin Hydrochloride had been in phase III clinical trials for the treatment of generalised anxiety disorders. However, this research has been discontinued[2]. β-Amino Acid Imagabalin Hydrochloride had been also in phase I clinical trials for the treatment of chronic kidney disease[3]. |
| Name | β-Amino Acid Imagabalin Hydrochloride |
| CAS | 610300-00-0 |
| Formula | C9H20ClNO2 |
| Molar Mass | 209.71 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Birch M, et al. A Simplified Process for the Manufacture of Imagabalin Hydrochloride (PD-0332334), an α2δ-Ligand for the Treatment of Generalised Anxiety Disorder. Org. Process Res. Dev., 2011, 15 (6), pp 1358–1364 |
β-Amino Acid Imagabalin Hydrochloride
CAS: 610300-00-0 F: C9H20ClNO2 W: 209.71
β-Amino Acid Imagabalin Hydrochloride (PD-0332334) is a ligand for the α2δ subunit of the voltage-dependent calcium c
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.